Microvascular coronary dysfunction and ischemic heart disease: where are we in 2014?

Trends Cardiovasc Med. 2015 Feb;25(2):98-103. doi: 10.1016/j.tcm.2014.09.013. Epub 2014 Nov 7.

Abstract

Many patients with angina and signs of myocardial ischemia on stress testing have no significant obstructive epicardial coronary disease. There are many potential coronary and non-coronary mechanisms for ischemia without obstructive epicardial coronary disease, and prominent among these is coronary microvascular and/or endothelial dysfunction. Patients with coronary microvascular and/or endothelial dysfunction are often at increased risk of adverse cardiovascular events, including ischemic events and heart failure despite preserved ventricular systolic function. In this article, we will review the diagnosis and treatment of coronary microvascular and endothelial dysfunction, discuss their potential contribution to heart failure with preserved ejection fraction, and highlight recent advances in the evaluation of atherosclerotic morphology in these patients, many of whom have non-obstructive epicardial disease.

Publication types

  • Review

MeSH terms

  • Coronary Artery Disease / diagnosis*
  • Coronary Artery Disease / therapy
  • Coronary Vessels / pathology*
  • Female
  • Humans
  • Male
  • Microvessels / pathology
  • Myocardial Ischemia / diagnosis*
  • Myocardial Ischemia / therapy